Global Micro-RNA Sequencing and Assay Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Micro-RNA Sequencing and Assay Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
MicroRNA sequencing (miRNA-seq), a type of RNA-Seq, is the use of next-generation sequencing or massively parallel high-throughput DNA sequencing to sequence microRNAs, also called miRNAs. miRNA-seq differs from other forms of RNA-seq in that input material is often enriched for small RNAs. miRNA-seq allows researchers to examine tissue-specific expression patterns, disease associations, and isoforms of miRNAs, and to discover previously uncharacterized miRNAs. Evidence that dysregulated miRNAs play a role in diseases such as cancer has positioned miRNA-seq to potentially become an important tool in the future for diagnostics and prognostics as costs continue to decrease.Like other miRNA profiling technologies, miRNA-Seq has both advantages (sequence-independence, coverage) and disadvantages (high cost, infrastructure requirements, run length, and potential artifacts).
Micro-RNA Sequencing and Assay report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Micro-RNA Sequencing and Assay market is projected to reach US$ 429.3 million in 2033, increasing from US$ 231 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2033. Demand from Research Institute and Academia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Micro-RNA Sequencing and Assay industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Micro-RNA Sequencing and Assay key companies include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Illumina, Thermo Fisher Scientific, QIAGEN are top 3 players and held % share in total in 2022.
Micro-RNA Sequencing and Assay can be divided into Sequencing by Synthesis, Sequencing by Nanopore and Ion Semiconductor Sequencing,, etc. Sequencing by Synthesis is the mainstream product in the market, accounting for % share globally in 2022.
Micro-RNA Sequencing and Assay is widely used in various fields, such as Research Institute, Academia and CRO,, etc. Research Institute provides greatest supports to the Micro-RNA Sequencing and Assay industry development. In 2022, global % share of Micro-RNA Sequencing and Assay went into Research Institute filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Micro-RNA Sequencing and Assay market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Micro-RNA Sequencing and Assay introduction, etc. Micro-RNA Sequencing and Assay Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Micro-RNA Sequencing and Assay market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Micro-RNA Sequencing and Assay report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Micro-RNA Sequencing and Assay market is projected to reach US$ 429.3 million in 2033, increasing from US$ 231 million in 2022, with the CAGR of 9.8% during the period of 2023 to 2033. Demand from Research Institute and Academia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Micro-RNA Sequencing and Assay industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033.
Globally, Micro-RNA Sequencing and Assay key companies include Illumina, Thermo Fisher Scientific, QIAGEN, Takara Bio and NEB, etc. Illumina, Thermo Fisher Scientific, QIAGEN are top 3 players and held % share in total in 2022.
Micro-RNA Sequencing and Assay can be divided into Sequencing by Synthesis, Sequencing by Nanopore and Ion Semiconductor Sequencing,, etc. Sequencing by Synthesis is the mainstream product in the market, accounting for % share globally in 2022.
Micro-RNA Sequencing and Assay is widely used in various fields, such as Research Institute, Academia and CRO,, etc. Research Institute provides greatest supports to the Micro-RNA Sequencing and Assay industry development. In 2022, global % share of Micro-RNA Sequencing and Assay went into Research Institute filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Micro-RNA Sequencing and Assay market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Illumina
Thermo Fisher Scientific
QIAGEN
Takara Bio
NEB
Segment by Type
Sequencing by Synthesis
Sequencing by Nanopore
Ion Semiconductor Sequencing
Segment by Application
Research Institute
Academia
CRO
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Micro-RNA Sequencing and Assay market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Micro-RNA Sequencing and Assay introduction, etc. Micro-RNA Sequencing and Assay Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Micro-RNA Sequencing and Assay market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.